Skip to main content
SEER
NASDAQ Industrial Applications And Services

Seer Appoints Anthony Bazarko as Chief Commercial Officer Amidst Activist Scrutiny

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Biotech Stocks · Healthcare
Sentiment info
Positive
Importance info
7
Price
$1.95
Mkt Cap
$110.021M
52W Low
$1.65
52W High
$2.41
52W Position info
18% above low
Off High info
19% below high
Rel. Volume info
2.0× avg
Market data snapshot near publication time

SEER sits 18% above its 52-week low of $1.65 on elevated volume (2.0× avg).

Summary

Seer, Inc. announced the appointment of Anthony Bazarko as Chief Commercial Officer, a key executive hire aimed at bolstering commercial strategy and growth amidst recent activist investor activity.


Key Events · Executive and Board Changes · SEER

  • New Chief Commercial Officer Appointed

    Seer, Inc. has appointed Anthony Bazarko to the role of Chief Commercial Officer, effective May 4, 2026.

  • Experienced Commercial Leader

    Mr. Bazarko brings over two decades of commercial leadership experience from the life sciences, diagnostics, and biotechnology sectors, with a track record of driving revenue growth and global go-to-market strategies.

  • Strategic Timing Amidst Activist Pressure

    This executive appointment follows recent unsolicited acquisition proposals from the Radoff-JEC Group and the Board's unanimous rejection, suggesting a focus on strengthening internal leadership to drive value.

  • Focus on Growth and Adoption

    Bazarko will lead the company's Sales, Marketing, and Customer Experience organizations, with a mandate to accelerate adoption of the Proteograph® Product Suite and expand access to proteomics solutions.


Analysis · SEER · Industrial Applications And Services

Seer, Inc. has appointed Anthony Bazarko as its new Chief Commercial Officer, a strategic move that comes amidst ongoing activist pressure from the Radoff-JEC Group. Bazarko's extensive background in global commercial leadership within the life sciences, diagnostics, and biotechnology industries is expected to be critical in accelerating growth and expanding the adoption of Seer's Proteograph Product Suite. This appointment signals the company's commitment to strengthening its commercial execution and could be interpreted as a proactive step to enhance shareholder value and address concerns raised by the activist investor regarding the company's operational performance and strategic direction.

How filings like this one have moved

In the 30 days to Nov 11, 2026, 36.6% of the 3434 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, SEER was trading at $1.95 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $110M. The 52-week trading range was $1.65 to $2.41. This filing was assessed with positive market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

SEER - Latest Insights

SEER
Nov 10, 2026, 4:22 PM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $1.55
Real-time Price: $1.60 info
Change: +$0.050 (+3%) info
Market Cap: $88.595M info
SEER
Nov 10, 2026, 4:06 PM EST
Source: Reuters
Importance Score:
7
Price at Filing: $1.54
Real-time Price: $1.60 info
Change: +$0.060 (+4%) info
Market Cap: $88.595M info
SEER
Nov 02, 2026, 2:08 PM EST
Filing Type: SCHEDULE 13D
Importance Score:
7
Price at Filing: $1.74
Real-time Price: $1.60 info
Change: -$0.135 (-8%) info
Market Cap: $88.595M info
SEER
Nov 02, 2026, 8:00 AM EST
Source: BusinessWire
Importance Score:
7
Price at Filing: $1.64
Real-time Price: $1.60 info
Change: -$0.040 (-2%) info
Market Cap: $88.595M info
SEER
Oct 29, 2026, 4:30 PM EDT
Source: Wiseek News
Importance Score:
8
Price at Filing: $1.75
Real-time Price: $1.60 info
Change: -$0.1523 (-9%) info
Market Cap: $88.595M info